| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.5M | +13.0% |
| Cost of Revenue | $15.3M | +6.3% |
| Gross Profit | $1.3M | +398.4% |
| R&D Expense | $1.2M | -13.9% |
| SG&A Expense | $5.7M | +0.3% |
| Operating Income | -$8.3M | +12.4% |
| Pre-tax Income | -$8.6M | +17.1% |
| Income Tax | -$1K | +96.3% |
| Net Income | -$8.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | — |
| Accounts Receivable | $3.4M | +43.2% |
| Inventory | $6.5M | +16.9% |
| Current Assets | $16.0M | -22.7% |
| Total Assets | $27.3M | -15.9% |
| Current Liabilities | $4.7M | -3.7% |
| Total Liabilities | $16.9M | +7.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +18.9% |
| Capital Expenditures | $395K | -71.1% |
| Investing Cash Flow | -$218K | +48.6% |
| Financing Cash Flow | $719K | -91.5% |
| Free Cash Flow | -$6.5M | +26.9% |
| +17.6% |
| EPS (Basic) | -$0.89 | +45.7% |
| Stockholders' Equity |
| $10.4M |
| -37.4% |